Hearing Aids Market - Global Forecast to 2030
商品番号 : SMB-4481
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年10月 |
| ページ数 | 293 |
| 図表数 | 380 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
補聴器市場 – 製品 [デバイス（RITE、BTE、カナル、ITE）、インプラント（人工内耳、骨伝導）]、難聴の種類（感音性、伝音性）、患者（成人、小児）、技術（デジタル、アナログ）、チャネルと地域別 – 2030年までの世界予測
世界の補聴器市場は、予測期間中に6.8%のCAGRで成長し、2025年の103.5億米ドルから2030年には144.2億米ドルに達すると予測されています。
補聴器市場の大幅な成長は、難聴の増加、高齢化の進展、そして聴覚関連疾患への意識の高まりによるもので、これらが市場の成長を牽引しています。さらに、スマートで使いやすいデジタル補聴器の普及も、市場拡大をさらに後押しすると予想されます。
本レポートは、補聴器市場を製品タイプ、難聴の種類、患者タイプ、技術、流通チャネル、地域の観点から分析しています。また、市場の成長に影響を与える推進要因、制約要因、機会、課題といった要因を考察し、市場リーダーの競争環境に関する詳細な情報を提供しています。さらに、ミクロ市場の成長傾向を分析し、5つの主要地域とそれぞれの国における市場セグメントの収益予測も提供しています。
本レポートは、既存企業だけでなく新規参入企業や小規模企業も市場の動向を把握し、より大きな市場シェアを獲得することを可能にします。本レポートを購入した企業は、以下に示す戦略のいずれか、または組み合わせて活用することで、市場プレゼンスを強化することができます。
Report Description
The global hearing aids market is projected to reach USD 14.42 billion by 2030 from USD 10.35 billion in 2025, at a CAGR of 6.8% during the forecast period.
The large growth in the hearing aids market is due to the increasing prevalence of hearing loss, the rising aging population, and growing awareness of hearing-related disorders, which drive market growth. Additionally, the increasing adoption of smart and user-friendly digital hearing aids is expected to further support market expansion.
“Audiology and ENT hospitals & clinics are the leading distribution channel in the hearing aids market.”
The hearing aids market is delineated by distribution channels, specifically categorized into audiology and ENT hospitals and clinics, retail and pharmacy outlets, and online platforms. In 2024, hospitals and clinics commanded the largest market share. These institutions provide a comprehensive continuum of hearing healthcare, encompassing diagnosis, device fitting, and post-fitting management, which is particularly critical for individuals with progressive or complex hearing impairments. The established trust in these facilities significantly enhances adoption rates. Audiology and ENT hospitals & clinics are typically staffed with qualified specialists and are equipped with soundproof testing environments, diagnostic apparatus, and surgical capabilities. They deliver non-surgical solutions and implantable hearing devices within a single location, streamlining the patient’s experience. Research indicates that optimized clinical frameworks—such as unbundled pricing models—further facilitate increased uptake of hearing aids. These healthcare settings remain preeminent in the market due to their ability to provide precise diagnostics, professional counsel, and integrated services for hearing aids and implantable devices.
“Digital hearing commanded the largest share in the hearing aids technology market in 2024.”
The global hearing aids market categorizes devices into digital and analog hearing aids. As of 2024, digital hearing aids accounted for the largest market share owing to their superior functionalities, including enhanced speech intelligibility and adaptive sound processing capabilities. These devices convert ambient noise into digital signals, which are then processed using sophisticated algorithms to optimize auditory perception, suppress unwanted background noise, and reduce acoustic feedback—features that are notably absent in traditional analog hearing aids. Digital hearing aids are predominantly prescribed by audiologists in clinical settings such as hospitals and specialized hearing care facilities. A significant number of contemporary models are equipped with wireless connectivity, allowing for remote adjustment and automatic adaptation to varying acoustic environments, thereby improving user convenience and overall experience. Meanwhile, analog hearing aids are experiencing a gradual decline in market presence; they remain primarily in use in low-cost settings, particularly in rural or infrastructure-limited regions of low- and middle-income countries, where access to digital technology and fitting services is restricted.
“Asia Pacific is expected to be the fastest-growing region of the hearing aids regional market during the study period.”
The global hearing aids market is categorized into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is witnessing rapid expansion, driven by a significant increase in the elderly demographic, heightened demand for otolaryngological services, and substantial investments in healthcare infrastructure. This region presents considerable growth potential for industry stakeholders and is anticipated to achieve the highest compound annual growth rate (CAGR) during the forecast period. As demographic aging progresses, nations such as South Korea, Taiwan, and Singapore observe a rising prevalence of hearing loss, escalating the demand for audiological care. Government initiatives aimed at enhancing healthcare access and expanding hospital and clinic networks have made hearing aids more accessible to the population. Furthermore, the region’s burgeoning medical tourism sector, particularly in Thailand and Malaysia, is facilitating an increase in the availability and adoption of hearing care solutions. These trends are expected to sustain robust market growth across the Asia Pacific region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 38%, Tier 2: 29%, and Tier 3: 33%
- By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
- By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the hearing aids market are Sonova (Switzerland), Demant A/S(Denmark), GN Store Nord A/S (Denmark), Cochlear Ltd. (Australia), Rion Co., Ltd. (Japan), Eargo Inc. (US), Starkey Laboratories, Inc. (US), WSAudiology (Denmark), Zhejiang Nurotron Biotechnology Co., Ltd. (China), and MED-EL Medical Electronics (Austria), among others.
Research Coverage
This report examines the hearing aids market based on product type, type of hearing loss, patient type, technology, distribution channel, and region. It also explores factors such as drivers, restraints, opportunities, and challenges that influence market growth, and provides details on the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of market segments across five major regions and their respective countries.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
Analysis of key drivers (increasing global burden of hearing loss, increase in aging population, supportive insurance coverage and expanding reimbursement access, increasing adoption of smart hearing aids amid rising noise-induced hearing loss), restraints (high cost of hearing aids and associated treatments, risks, accessibility, and long post-surgery rehabilitation associated with hearing aid), opportunities (high-growth potential for hearing technologies in emerging economies, integration with digital health platforms enhances hearing device care), and challenges (shortage of skilled professionals performing ENT Procedures).
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hearing aids market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the hearing aids market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the hearing aids market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 INCLUSIONS AND EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 30
1.4 CURRENCY CONSIDERED 31
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 35
2.1.2.1 Primary sources 35
2.1.2.2 Key industry insights 36
2.1.2.3 Key data from primary sources 36
2.1.2.4 Breakdown of primary interviews 37
2.2 MARKET SIZE ESTIMATION 38
2.2.1 BOTTOM-UP APPROACH 38
2.2.1.1 Approach 1: Company revenue estimation approach 38
2.2.1.2 Approach 2: Presentations of companies and primary interviews 38
2.2.1.3 Approach 3: Primary interviews 39
2.2.1.4 Growth forecast 39
2.2.1.5 CAGR projections 39
2.2.2 TOP-DOWN APPROACH 40
2.3 DATA TRIANGULATION 41
2.4 RESEARCH ASSUMPTIONS 42
2.4.1 STUDY-RELATED ASSUMPTIONS 42
2.4.2 PARAMETRIC ASSUMPTIONS 42
2.4.3 GROWTH RATE ASSUMPTIONS 42
2.5 RESEARCH LIMITATIONS 43
2.6 RISK ASSESSMENT 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 50
4.1 HEARING AIDS MARKET OVERVIEW 50
4.2 ASIA PACIFIC: HEARING AIDS CARE MARKET SHARE, BY DISTRIBUTION CHANNEL
AND COUNTRY 51
4.3 HEARING AIDS MARKET, BY KEY COUNTRY 52
4.4 HEARING AIDS MARKET, REGIONAL MIX 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increase in global burden of hearing loss 54
5.2.1.2 Increase in aging population 54
5.2.1.3 Supportive insurance coverage and expanding reimbursement access 55
5.2.1.4 Increase in adoption of smart hearing aids amid rising noise-induced hearing loss 56
5.2.2 RESTRAINTS 57
5.2.2.1 High cost of hearing aids and associated treatments 57
5.2.2.2 Risks, accessibility, and long post-surgery rehabilitation associated with hearing aids 57
5.2.3 OPPORTUNITIES 59
5.2.3.1 High-growth potential for hearing technologies in emerging economies 59
5.2.3.2 Integration with digital health platforms to enhance hearing device care 60
5.2.4 CHALLENGES 61
5.2.4.1 Shortage of skilled professionals performing ENT procedures 61
5.3 PRICING ANALYSIS 62
5.3.1 AVERAGE SELLING PRICE TREND OF HEARING AID PRODUCTS, BY REGION 62
5.3.2 AVERAGE SELLING PRICE TREND OF HEARING AID PRODUCTS,
BY KEY PLAYER 62
5.4 VALUE CHAIN ANALYSIS 63
5.5 SUPPLY CHAIN ANALYSIS 64
5.6 ECOSYSTEM ANALYSIS 65
5.7 PORTER’S FIVE FORCES ANALYSIS 66
5.7.1 THREAT OF NEW ENTRANTS 67
5.7.2 THREAT OF SUBSTITUTES 67
5.7.3 BARGAINING POWER OF BUYERS 68
5.7.4 BARGAINING POWER OF SUPPLIERS 68
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 68
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 68
5.8.2 KEY BUYING CRITERIA 69
5.9 REGULATORY ANALYSIS 70
5.9.1 REGULATORY FRAMEWORK 70
5.9.1.1 North America 70
5.9.1.1.1 US 70
5.9.1.1.2 Canada 71
5.9.1.2 Europe 71
5.9.1.3 Asia Pacific 72
5.9.1.3.1 Japan 72
5.9.1.3.2 China 73
5.9.1.3.3 India 73
5.9.1.4 Latin America 74
5.9.1.4.1 Brazil 74
5.9.1.4.2 Mexico 74
5.9.1.5 Middle East 74
5.9.1.6 Africa 74
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.10 TRADE ANALYSIS 77
5.10.1 IMPORT DATA (HS CODE 902140) 77
5.10.2 EXPORT DATA (HS CODE 902140) 77
5.11 PATENT ANALYSIS 78
5.11.1 LIST OF MAJOR PATENTS 79
5.12 KEY CONFERENCES & EVENTS 80
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.14 TECHNOLOGY ANALYSIS 83
5.14.1 KEY TECHNOLOGIES 83
5.14.1.1 Digital signal processing (DSP) 83
5.14.2 COMPLEMENTARY TECHNOLOGIES 83
5.14.2.1 Bimodal hearing solutions 83
5.14.3 ADJACENT TECHNOLOGIES 84
5.14.3.1 Cochlear implants & bone-anchored hearing systems 84
5.15 INVESTMENT & FUNDING SCENARIO 84
5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET 85
5.17 CASE STUDY ANALYSIS 85
5.17.1 ADVANCING HEARING CAPABILITY WITH INTEGRATED COCHLEAR IMPLANT AND HEARING AID TECHNOLOGY 85
5.17.2 WIDEX MOMENT EXPERIENCE: RESTORING SOUND PRECISION THROUGH ADVANCED HEARING TECHNOLOGY 86
5.17.3 NANCY E. AND BAHA SYSTEM: REDISCOVERING SOUND AFTER FIVE DECADES 86
5.18 IMPACT OF AI ON HEARING AIDS MARKET 87
5.18.1 INTRODUCTION 87
5.18.2 MARKET POTENTIAL OF AI IN HEARING AIDS MARKET 87
5.18.3 AI USE CASES 88
5.18.4 KEY COMPANIES IMPLEMENTING AI 88
5.18.5 FUTURE OF AI IN HEARING AIDS MARKET 89
5.19 IMPACT OF US TARIFF REGULATION ON HEARING AIDS MARKET 89
5.19.1 INTRODUCTION 89
5.19.2 KEY TARIFF RATES 90
5.19.3 PRICE IMPACT ANALYSIS 90
5.19.4 KEY IMPACTS ON COUNTRY/REGION 91
5.19.4.1 North America 91
5.19.4.2 Europe 91
5.19.4.3 Asia Pacific 91
5.19.5 IMPACT ON END-USE INDUSTRIES 92
5.19.5.1 Audiology and ENT hospitals & clinics 92
6 HEARING AIDS MARKET, BY PRODUCT 93
6.1 INTRODUCTION 94
6.2 HEARING AID DEVICES 94
6.2.1 RECEIVER-IN-THE-EAR HEARING AIDS 98
6.2.1.1 Designed to manage mild to severe hearing loss 98
6.2.2 BEHIND-THE-EAR HEARING AIDS 101
6.2.2.1 Affordability and advancements in BTE hearing aids to drive growth 101
6.2.3 CANAL HEARING AIDS 104
6.2.3.1 Technological innovations and low visibility to drive demand for canal aids 104
6.2.4 IN-THE-EAR HEARING AIDS 106
6.2.4.1 Custom fit and advanced functionality of ITE hearing aids to drive market expansion 106
6.2.5 OTHER HEARING AID DEVICES 109
6.3 HEARING IMPLANTS 112
6.3.1 COCHLEAR IMPLANTS 114
6.3.1.1 Cochlear implants to lead hearing implants market 114
6.3.2 BONE-ANCHORED SYSTEMS 117
6.3.2.1 Rise in adoption of bone-anchored hearing systems in single-sided deafness and conductive hearing loss 117
7 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS 121
7.1 INTRODUCTION 122
7.2 SENSORINEURAL HEARING LOSS 122
7.2.1 GROWTH OF ELDERLY POPULATION TO DRIVE SENSORINEURAL HEARING LOSS SEGMENT 122
7.3 CONDUCTIVE HEARING LOSS 125
7.3.1 TECHNOLOGICAL INNOVATIONS AND REGULATORY APPROVALS TO FUEL GROWTH OF CONDUCTIVE HEARING LOSS SEGMENT 125
8 HEARING AIDS MARKET, BY PATIENT TYPE 129
8.1 INTRODUCTION 130
8.2 ADULTS 130
8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS KEY SEGMENT OF OVERALL PATIENT POOL 130
8.3 PEDIATRICS 133
8.3.1 TECHNOLOGICAL ADVANCEMENTS TO FUEL GROWTH OF PEDIATRIC HEARING AIDS 133
9 HEARING AIDS MARKET, BY TECHNOLOGY 137
9.1 INTRODUCTION 138
9.2 DIGITAL 138
9.2.1 PRECISION SOUND TAILORED THROUGH DIGITAL PROCESSING TO PROPEL MARKET 138
9.3 ANALOG 140
9.3.1 ANALOG: AFFORDABLE SOLUTIONS FOR BASIC HEARING NEEDS 140
10 HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL 144
10.1 INTRODUCTION 145
10.2 AUDIOLOGY AND ENT HOSPITALS & CLINICS 145
10.2.1 EXPERT-LED CARE IN CLINICAL SETTINGS TO DRIVE HIGHER ADOPTION AND SATISFACTION 145
10.3 RETAIL & PHARMACY STORES 148
10.3.1 EXPANDING ACCESS TO HEARING CARE THROUGH CONVENIENT AND AFFORDABLE IN-STORE OPTIONS 148
10.4 ONLINE SALES 151
10.4.1 EMERGING CHANNEL OFFERING REMOTE ACCESS TO HEARING AIDS 151
11 HEARING AIDS MARKET, BY REGION 155
11.1 INTRODUCTION 156
11.2 NORTH AMERICA 157
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 157
11.2.2 US 161
11.2.2.1 US to lead North America’s hearing aids market through 2030 161
11.2.3 CANADA 164
11.2.3.1 Targeted awareness-raising and aging trends to drive steady growth in Canada’s hearing aids market 164
11.3 EUROPE 167
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 167
11.3.2 GERMANY 170
11.3.2.1 Growth in healthcare expenditure in Germany to drive demand for advanced hearing aids 170
11.3.3 UK 173
11.3.3.1 Rise in burden of hearing loss continues to fuel market expansion
in UK 173
11.3.4 FRANCE 176
11.3.4.1 Investment in R&D and technological innovation to drive market expansion in France 176
11.3.5 SPAIN 179
11.3.5.1 Rise in life expectancy and aging population to boost market growth 179
11.3.6 ITALY 182
11.3.6.1 Rise in Italy’s elderly population to create further potential demand for hearing aids 182
11.3.7 REST OF EUROPE 185
11.4 ASIA PACIFIC 188
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 188
11.4.2 CHINA 192
11.4.2.1 China to continue dominating Asia Pacific hearing aids market 192
11.4.3 INDIA 195
11.4.3.1 Healthcare infrastructure improvements to drive hearing aids market growth 195
11.4.4 JAPAN 198
11.4.4.1 Aging population and favorable insurance policies to support adoption in Japan 198
11.4.5 AUSTRALIA 201
11.4.5.1 Rise in geriatric population and government programs to accelerate market growth 201
11.4.6 REST OF ASIA PACIFIC 204
11.5 LATIN AMERICA 207
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 207
11.5.2 BRAZIL 211
11.5.2.1 Largest healthcare sector in region and government initiatives to drive market 211
11.5.3 MEXICO 214
11.5.3.1 Expanding hospital infrastructure to support hearing healthcare growth 214
11.5.4 REST OF LATIN AMERICA 216
11.6 MIDDLE EAST & AFRICA 220
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 220
12 COMPETITIVE LANDSCAPE 224
12.1 OVERVIEW 224
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 224
12.3 REVENUE ANALYSIS, 2022–2024 226
12.4 MARKET SHARE ANALYSIS, 2024 227
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 229
12.5.1 STARS 229
12.5.2 EMERGING LEADERS 230
12.5.3 PERVASIVE PLAYERS 230
12.5.4 PARTICIPANTS 230
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 231
12.5.5.1 Company footprint 231
12.5.5.2 Regional footprint 231
12.5.5.3 Product footprint 232
12.5.5.4 Type of hearing loss footprint 232
12.5.5.5 Patient type footprint 233
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 233
12.6.1 PROGRESSIVE COMPANIES 233
12.6.2 RESPONSIVE COMPANIES 233
12.6.3 DYNAMIC COMPANIES 234
12.6.4 STARTING BLOCKS 234
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 235
12.6.5.1 Detailed list of key startups/SMEs 235
12.6.5.2 Competitive benchmarking of key startups/SMEs 236
12.7 COMPANY VALUATION AND FINANCIAL METRICS 237
12.7.1 COMPANY VALUATION 237
12.7.2 FINANCIAL METRICS 238
12.8 BRAND/PRODUCT COMPARISON 238
12.9 COMPETITIVE SCENARIO 239
12.9.1 PRODUCT LAUNCHES & APPROVALS 239
12.9.2 DEALS 242
12.9.3 EXPANSIONS 244
12.9.4 OTHER DEVELOPMENTS 244
13 COMPANY PROFILES 245
13.1 KEY PLAYERS 245
13.1.1 SONOVA 245
13.1.1.1 Business overview 245
13.1.1.2 Products offered 246
13.1.1.3 Recent developments 247
13.1.1.3.1 Product launches & approvals 247
13.1.1.3.2 Deals 248
13.1.1.3.3 Expansions 249
13.1.1.4 MnM view 249
13.1.1.4.1 Right to win 249
13.1.1.4.2 Strategic choices 249
13.1.1.4.3 Weaknesses & competitive threats 249
13.1.2 WSAUDIOLOGY 250
13.1.2.1 Business overview 250
13.1.2.2 Products offered 251
13.1.2.3 Recent developments 251
13.1.2.3.1 Product launches & approvals 251
13.1.2.3.2 Deals 252
13.1.2.4 MnM view 252
13.1.2.4.1 Right to win 252
13.1.2.4.2 Strategic choices 252
13.1.2.4.3 Weaknesses & competitive threats 253
13.1.3 DEMANT A/S 254
13.1.3.1 Business overview 254
13.1.3.2 Products offered 255
13.1.3.3 Recent developments 257
13.1.3.3.1 Product launches & approvals 257
13.1.3.3.2 Deals 258
13.1.3.3.3 Expansions 258
13.1.3.3.4 Other developments 259
13.1.3.4 MnM view 259
13.1.3.4.1 Right to win 259
13.1.3.4.2 Strategic choices 259
13.1.3.4.3 Weaknesses & competitive threats 259
13.1.4 COCHLEAR LTD. 260
13.1.4.1 Business overview 260
13.1.4.2 Products offered 261
13.1.4.3 Recent developments 262
13.1.4.3.1 Product launches & approvals 262
13.1.4.4 MnM view 262
13.1.4.4.1 Right to win 262
13.1.4.4.2 Strategic choices 262
13.1.4.4.3 Weaknesses & competitive threats 263
13.1.5 GN STORE NORD A/S 264
13.1.5.1 Business overview 264
13.1.5.2 Products offered 265
13.1.5.3 Recent developments 266
13.1.5.3.1 Product launches & approvals 266
13.1.5.3.2 Deals 267
13.1.5.3.3 Other developments 267
13.1.5.4 MnM view 267
13.1.5.4.1 Right to win 267
13.1.5.4.2 Strategic choices 267
13.1.5.4.3 Weaknesses & competitive threats 267
13.1.6 STARKEY LABORATORIES, INC. 268
13.1.6.1 Business overview 268
13.1.6.2 Products offered 268
13.1.6.3 Recent developments 269
13.1.6.3.1 Product launches & approvals 269
13.1.6.3.2 Deals 269
13.1.7 MED-EL MEDICAL ELECTRONICS 270
13.1.7.1 Business overview 270
13.1.7.2 Products offered 270
13.1.7.3 Recent developments 270
13.1.7.3.1 Deals 270
13.1.8 EARGO INC. 272
13.1.8.1 Business overview 272
13.1.8.2 Products offered 272
13.1.9 RION CO., LTD. 273
13.1.9.1 Business overview 273
13.1.9.2 Products offered 274
13.1.9.3 Recent developments 275
13.1.9.3.1 Deals 275
13.1.10 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. 276
13.1.10.1 Business overview 276
13.1.10.2 Products offered 276
13.2 OTHER PLAYERS 277
13.2.1 AUDINA HEARING INSTRUMENTS, INC. 277
13.2.2 NEUBIO AG 278
13.2.3 HORENTEK HEARING DIAGNOSTICS 278
13.2.4 SEBOTEK HEARING SYSTEMS, LLC 279
13.2.5 ARPHI ELECTRONICS PRIVATE LIMITED 279
13.2.6 IN4 TECHNOLOGY CORPORATION 280
13.2.7 AUDICUS 281
13.2.8 NANO HEARING AIDS 281
13.2.9 LORECA HEARING AID 282
13.2.10 EARLENS CORP. 282
13.2.11 AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD. 283
13.2.12 SHANGHAI LISTENT MEDICAL TECH CO., LTD. 284
13.2.13 AUDIFON GMBH & CO. KG 284
13.2.14 FOSHAN VOHOM TECHNOLOGY CO., LTD. 285
13.2.15 TODOC CO., LTD. 285
14 APPENDIX 286
14.1 DISCUSSION GUIDE 286
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 289
14.3 CUSTOMIZATION OPTIONS 291
14.4 RELATED REPORTS 291
14.5 AUTHOR DETAILS 292
LIST OF TABLES
TABLE 1 HEARING AIDS MARKET: INCLUSIONS AND EXCLUSIONS 30
TABLE 2 KEY DATA FROM PRIMARY SOURCES 36
TABLE 3 HEARING AIDS MARKET: RISK ASSESSMENT 43
TABLE 4 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION,
2023 VS. 2030 VS. 2050 55
TABLE 5 AVERAGE SELLING PRICE TREND OF HEARING AID PRODUCTS, BY REGION,
2023–2025 (USD) 62
TABLE 6 AVERAGE SELLING PRICE TREND OF HEARING AID PRODUCTS, BY KEY PLAYER, 2023-2025 (USD) 62
TABLE 7 HEARING AIDS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 66
TABLE 8 HEARING AIDS MARKET: PORTER’S FIVE FORCES 66
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 69
TABLE 10 KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNEL 69
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION 70
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71
TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71
TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 72
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 21 IMPORT DATA (HS CODE 902140), BY COUNTRY, 2020–2024 (USD MILLION) 77
TABLE 22 EXPORT DATA (HS CODE 902140), BY COUNTRY, 2020–2024 (USD MILLION) 77
TABLE 23 HEARING AIDS MARKET: LIST OF MAJOR PATENTS 79
TABLE 24 HEARING AIDS MARKET: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2025–DECEMBER 2026 80
TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES, 2024 90
TABLE 26 HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 94
TABLE 27 KEY PRODUCTS IN HEARING AID DEVICES MARKET 94
TABLE 28 HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 96
TABLE 29 HEARING AID DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 96
TABLE 30 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 31 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 32 ASIA PACIFIC: HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 33 LATIN AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 34 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 35 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 36 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 37 ASIA PACIFIC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 38 LATIN AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 39 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2023–2030 (USD MILLION) 102
TABLE 40 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 102
TABLE 41 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 42 ASIA PACIFIC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 43 LATIN AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 44 CANAL HEARING AIDS MARKET, BY REGION, 2023–2030 (USD MILLION) 105
TABLE 45 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 46 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 47 ASIA PACIFIC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 48 LATIN AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 49 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2023–2030 (USD MILLION) 107
TABLE 50 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 51 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 52 ASIA PACIFIC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 53 LATIN AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 54 OTHER HEARING AID DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 55 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 56 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 57 ASIA PACIFIC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 58 LATIN AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 59 KEY PRODUCTS IN HEARING AID DEVICES MARKET 112
TABLE 60 HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112
TABLE 61 HEARING IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 62 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 63 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 64 ASIA PACIFIC: HEARING IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 65 LATIN AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 66 COCHLEAR IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 67 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 68 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 69 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 70 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 71 BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 72 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 73 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 74 ASIA PACIFIC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 75 LATIN AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 76 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023–2030 (USD MILLION) 122
TABLE 77 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 78 NORTH AMERICA: HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 79 EUROPE: HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS,
BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 80 ASIA PACIFIC: HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 81 LATIN AMERICA: HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 82 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 83 NORTH AMERICA: HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS,
BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 84 EUROPE: HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 85 ASIA PACIFIC: HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS,
BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 86 LATIN AMERICA: HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS,
BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 87 HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 130
TABLE 88 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2023–2030 (USD MILLION) 131
TABLE 89 NORTH AMERICA: HEARING AIDS MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 90 EUROPE: HEARING AIDS MARKET FOR ADULT PATIENTS, BY COUNTRY,
2023–2030 (USD MILLION) 132
TABLE 91 ASIA PACIFIC: HEARING AIDS MARKET FOR ADULT PATIENTS, BY COUNTRY,
2023–2030 (USD MILLION) 132
TABLE 92 LATIN AMERICA: HEARING AIDS MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 93 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2023–2030 (USD MILLION) 134
TABLE 94 NORTH AMERICA: HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 95 EUROPE: HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 96 ASIA PACIFIC: HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 97 LATIN AMERICA: HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 98 HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 138
TABLE 99 DIGITAL HEARING AIDS MARKET, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 100 NORTH AMERICA: DIGITAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 139
TABLE 101 EUROPE: DIGITAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 139
TABLE 102 ASIA PACIFIC: DIGITAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 140
TABLE 103 LATIN AMERICA: DIGITAL HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 140
TABLE 104 ANALOG HEARING AIDS MARKET, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 105 NORTH AMERICA: ANALOG HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 142
TABLE 106 EUROPE: ANALOG HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 142
TABLE 107 ASIA PACIFIC: ANALOG HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 108 LATIN AMERICA: ANALOG HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 109 HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 145
TABLE 110 HEARING AIDS MARKET THROUGH AUDIOLOGY AND ENT HOSPITALS & CLINICS,
BY REGION, 2023–2030 (USD MILLION) 146
TABLE 111 NORTH AMERICA: HEARING AIDS MARKET THROUGH AUDIOLOGY AND ENT HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 112 EUROPE: HEARING AIDS MARKET THROUGH AUDIOLOGY AND ENT HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 113 ASIA PACIFIC: HEARING AIDS MARKET THROUGH AUDIOLOGY AND ENT HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 114 LATIN AMERICA: HEARING AIDS MARKET THROUGH AUDIOLOGY AND ENT HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 115 HEARING AIDS MARKET THROUGH RETAIL & PHARMACY STORES, BY REGION, 2023–2030 (USD MILLION) 149
TABLE 116 NORTH AMERICA: HEARING AIDS MARKET THROUGH RETAIL & PHARMACY STORES, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 117 EUROPE: HEARING AIDS MARKET THROUGH RETAIL & PHARMACY STORES,
BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 118 ASIA PACIFIC: HEARING AIDS MARKET THROUGH RETAIL & PHARMACY STORES,
BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 119 LATIN AMERICA: HEARING AIDS MARKET THROUGH RETAIL & PHARMACY STORES, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 120 HEARING AIDS MARKET THROUGH ONLINE SALES, BY REGION,
2023–2030 (USD MILLION) 152
TABLE 121 NORTH AMERICA: HEARING AIDS MARKET THROUGH ONLINE SALES, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 122 EUROPE: HEARING AIDS MARKET THROUGH ONLINE SALES, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 123 ASIA PACIFIC: HEARING AIDS MARKET THROUGH ONLINE SALES, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 124 LATIN AMERICA: HEARING AIDS MARKET THROUGH ONLINE SALES, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 125 HEARING AIDS SOLD GLOBALLY, 2023–2030 (MILLION UNITS) 156
TABLE 126 HEARING AIDS MARKET, BY REGION, 2023–2030 (USD MILLION) 156
TABLE 127 NORTH AMERICA: MACROECONOMIC INDICATORS 157
TABLE 128 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 158
TABLE 129 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 159
TABLE 130 NORTH AMERICA: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 131 NORTH AMERICA: HEARING IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 132 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 160
TABLE 133 NORTH AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 160
TABLE 134 NORTH AMERICA: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 160
TABLE 135 NORTH AMERICA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 161
TABLE 136 US: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161
TABLE 137 US: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 138 US: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 139 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 162
TABLE 140 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 163
TABLE 141 US: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 163
TABLE 142 US: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 163
TABLE 143 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164
TABLE 144 CANADA: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 145 CANADA: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 146 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 165
TABLE 147 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 166
TABLE 148 CANADA: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 166
TABLE 149 CANADA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 166
TABLE 150 EUROPE: MACROECONOMIC INDICATORS 167
TABLE 151 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 152 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168
TABLE 153 EUROPE: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 154 EUROPE: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 155 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 169
TABLE 156 EUROPE: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 169
TABLE 157 EUROPE: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 169
TABLE 158 EUROPE: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 170
TABLE 159 GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171
TABLE 160 GERMANY: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 161 GERMANY: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 162 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 172
TABLE 163 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 172
TABLE 164 GERMANY: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 172
TABLE 165 GERMANY: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 173
TABLE 166 UK: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174
TABLE 167 UK: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 168 UK: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 169 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 175
TABLE 170 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 175
TABLE 171 UK: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 175
TABLE 172 UK: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 176
TABLE 173 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177
TABLE 174 FRANCE: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 175 FRANCE: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 176 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 178
TABLE 177 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 178
TABLE 178 FRANCE: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 178
TABLE 179 FRANCE: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 179
TABLE 180 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180
TABLE 181 SPAIN: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 182 SPAIN: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 183 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 181
TABLE 184 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 181
TABLE 185 SPAIN: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 181
TABLE 186 SPAIN: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 182
TABLE 187 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182
TABLE 188 ITALY: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 189 ITALY: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 190 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 183
TABLE 191 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 184
TABLE 192 ITALY: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 184
TABLE 193 ITALY: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 184
TABLE 194 REST OF EUROPE: HEARING AIDS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 185
TABLE 195 REST OF EUROPE: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 196 REST OF EUROPE: HEARING IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 197 REST OF EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 186
TABLE 198 REST OF EUROPE: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 187
TABLE 199 REST OF EUROPE: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 187
TABLE 200 REST OF EUROPE: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 187
TABLE 201 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 188
TABLE 202 ASIA PACIFIC: HEARING AIDS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 203 ASIA PACIFIC: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190
TABLE 204 ASIA PACIFIC: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 205 ASIA PACIFIC: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 206 ASIA PACIFIC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 191
TABLE 207 ASIA PACIFIC: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 191
TABLE 208 ASIA PACIFIC: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 192
TABLE 209 ASIA PACIFIC: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 192
TABLE 210 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193
TABLE 211 CHINA: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 212 CHINA: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 213 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 194
TABLE 214 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 194
TABLE 215 CHINA: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 194
TABLE 216 CHINA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 195
TABLE 217 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196
TABLE 218 INDIA: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 219 INDIA: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 220 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 197
TABLE 221 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 197
TABLE 222 INDIA: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 197
TABLE 223 INDIA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 198
TABLE 224 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199
TABLE 225 JAPAN: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 226 JAPAN: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 227 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 200
TABLE 228 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 200
TABLE 229 JAPAN: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 200
TABLE 230 JAPAN: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 201
TABLE 231 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 202
TABLE 232 AUSTRALIA: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 233 AUSTRALIA: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 234 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 203
TABLE 235 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 203
TABLE 236 AUSTRALIA: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 203
TABLE 237 AUSTRALIA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 204
TABLE 238 REST OF ASIA PACIFIC: HEARING AIDS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 205
TABLE 239 REST OF ASIA PACIFIC: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 240 REST OF ASIA PACIFIC: HEARING IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 241 REST OF ASIA PACIFIC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023–2030 (USD MILLION) 206
TABLE 242 REST OF ASIA PACIFIC: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 206
TABLE 243 REST OF ASIA PACIFIC: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 206
TABLE 244 REST OF ASIA PACIFIC: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 207
TABLE 245 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 207
TABLE 246 LATIN AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 208
TABLE 247 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 208
TABLE 248 LATIN AMERICA: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 249 LATIN AMERICA: HEARING IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 250 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 209
TABLE 251 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 210
TABLE 252 LATIN AMERICA: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 210
TABLE 253 LATIN AMERICA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 210
TABLE 254 BRAZIL: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 211
TABLE 255 BRAZIL: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 256 BRAZIL: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 257 BRAZIL: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 212
TABLE 258 BRAZIL: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 213
TABLE 259 BRAZIL: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 213
TABLE 260 BRAZIL: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 213
TABLE 261 MEXICO: HEARING AIDS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 214
TABLE 262 MEXICO: HEARING AID DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 263 MEXICO: HEARING IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 264 MEXICO: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2023–2030 (USD MILLION) 215
TABLE 265 MEXICO: HEARING AIDS MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 215
TABLE 266 MEXICO: HEARING AIDS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 216
TABLE 267 MEXICO: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 216
TABLE 268 REST OF LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 217
TABLE 269 REST OF LATIN AMERICA: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 217
TABLE 270 REST OF LATIN AMERICA: HEARING IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 271 REST OF LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023–2030 (USD MILLION) 218
TABLE 272 REST OF LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 218
TABLE 273 REST OF LATIN AMERICA: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 219
TABLE 274 REST OF LATIN AMERICA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 219
TABLE 275 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 220
TABLE 276 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 221
TABLE 277 MIDDLE EAST & AFRICA: HEARING AID DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 278 MIDDLE EAST & AFRICA: HEARING IMPLANTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 279 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023–2030 (USD MILLION) 222
TABLE 280 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 222
TABLE 281 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 222
TABLE 282 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 223
TABLE 283 HEARING AIDS MARKET: OVERVIEW OF STRATEGIES DEPLOYED
BY KEY MANUFACTURING COMPANIES, JANUARY 2022–MAY 2025 225
TABLE 284 HEARING AIDS MARKET: DEGREE OF COMPETITION 228
TABLE 285 HEARING AIDS MARKET: REGIONAL FOOTPRINT, 2024 231
TABLE 286 HEARING AIDS MARKET: PRODUCT FOOTPRINT, 2024 232
TABLE 287 HEARING AIDS MARKET: TYPE OF HEARING LOSS FOOTPRINT, 2024 232
TABLE 288 HEARING AIDS MARKET: PATIENT TYPE FOOTPRINT, 2024 233
TABLE 289 HEARING AIDS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 235
TABLE 290 HEARING AIDS MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES, 2024 236
TABLE 291 HEARING AIDS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–MAY 2025 239
TABLE 292 HEARING AIDS MARKET: DEALS, JANUARY 2022–MAY 2025 242
TABLE 293 HEARING AIDS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 244
TABLE 294 HEARING AIDS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 244
TABLE 295 SONOVA: COMPANY OVERVIEW 245
TABLE 296 SONOVA: PRODUCTS OFFERED 246
TABLE 297 SONOVA: PRODUCT LAUNCHES & APPROVALS 247
TABLE 298 SONOVA: DEALS 248
TABLE 299 SONOVA: EXPANSIONS 249
TABLE 300 WSAUDIOLOGY: COMPANY OVERVIEW 250
TABLE 301 WSAUDIOLOGY: PRODUCTS OFFERED 251
TABLE 302 WSAUDIOLOGY: PRODUCT LAUNCHES & APPROVALS 251
TABLE 303 WSAUDIOLOGY: DEALS 252
TABLE 304 DEMANT A/S: COMPANY OVERVIEW 254
TABLE 305 DEMANT A/S: PRODUCTS OFFERED 255
TABLE 306 DEMANT A/S: PRODUCT LAUNCHES & APPROVALS 257
TABLE 307 DEMANT A/S: DEALS 258
TABLE 308 DEMANT A/S: EXPANSIONS 258
TABLE 309 DEMANT A/S: OTHER DEVELOPMENTS 259
TABLE 310 COCHLEAR LTD.: COMPANY OVERVIEW 260
TABLE 311 COCHLEAR LTD.: PRODUCTS OFFERED 261
TABLE 312 COCHLEAR LTD.: PRODUCT LAUNCHES & APPROVALS 262
TABLE 313 GN STORE NORD A/S: COMPANY OVERVIEW 264
TABLE 314 GN STORE NORD A/S: PRODUCTS OFFERED 265
TABLE 315 GN STORE NORD A/S: PRODUCT LAUNCHES & APPROVALS 266
TABLE 316 GN STORE NORD A/S: DEALS, JANUARY 2022–MAY 2025 267
TABLE 317 GN STORE NORD A/S: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 267
TABLE 318 STARKEY LABORATORIES, INC.: COMPANY OVERVIEW 268
TABLE 319 STARKEY LABORATORIES, INC.: PRODUCTS OFFERED 268
TABLE 320 STARKEY LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS 269
TABLE 321 STARKEY LABORATORIES, INC.: DEALS 269
TABLE 322 MED-EL MEDICAL ELECTRONICS: COMPANY OVERVIEW 270
TABLE 323 MED-EL MEDICAL ELECTRONICS: PRODUCTS OFFERED 270
TABLE 324 MED-EL MEDICAL ELECTRONICS: DEALS 270
TABLE 325 EARGO INC.: COMPANY OVERVIEW 272
TABLE 326 EARGO INC.: PRODUCTS OFFERED 272
TABLE 327 RION CO., LTD.: COMPANY OVERVIEW 273
TABLE 328 RION CO., LTD.: PRODUCTS OFFERED 274
TABLE 329 RION CO., LTD.: DEALS 275
TABLE 330 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 276
TABLE 331 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 276
LIST OF FIGURES
FIGURE 1 HEARING AIDS MARKET SEGMENTATION 29
FIGURE 2 STUDY YEARS CONSIDERED 30
FIGURE 3 HEARING AIDS MARKET: RESEARCH DESIGN 33
FIGURE 4 KEY DATA FROM SECONDARY SOURCES 34
FIGURE 5 PRIMARY SOURCES 35
FIGURE 6 KEY INDUSTRY INSIGHTS 36
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION,
AND REGION 37
FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 38
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
FIGURE 10 HEARING AIDS MARKET: TOP-DOWN APPROACH 40
FIGURE 11 DATA TRIANGULATION METHODOLOGY 41
FIGURE 12 HEARING AIDS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 44
FIGURE 13 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2025 VS. 2030 (USD MILLION) 45
FIGURE 14 HEARING AIDS MARKET, BY PATIENT TYPE, 2025 VS. 2030 (USD MILLION) 45
FIGURE 15 HEARING AIDS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 46
FIGURE 16 HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL,
2025 VS. 2030 (USD MILLION) 47
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF HEARING AIDS MARKET 48
FIGURE 18 INCREASING PREVALENCE OF HEARING LOSS AND GROWING GERIATRIC POPULATION TO DRIVE MARKET 50
FIGURE 19 AUDIOLOGY AND ENT HOSPITALS & CLINICS ACCOUNTED FOR LARGEST SHARE
IN ASIA PACIFIC IN 2024 51
FIGURE 20 INDIA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 52
FIGURE 21 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 52
FIGURE 22 HEARING AIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 53
FIGURE 23 HEARING AIDS MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 24 COCHLEAR IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS 65
FIGURE 25 HEARING AIDS MARKET: ECOSYSTEM ANALYSIS 65
FIGURE 26 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 67
FIGURE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 68
FIGURE 28 KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNEL 69
FIGURE 29 PATENT ANALYSIS FOR HEARING AIDS, JANUARY 2015–DECEMBER 2024 78
FIGURE 30 HEARING AIDS MARKET: TRENDS AND DISRUPTIONS
IMPACTING CUSTOMERS’ BUSINESSES 82
FIGURE 31 HEARING AIDS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2025 84
FIGURE 32 AI USE CASES 88
FIGURE 33 NORTH AMERICA: HEARING AIDS MARKET SNAPSHOT 158
FIGURE 34 ASIA PACIFIC: HEARING DEVICES MARKET SNAPSHOT 189
FIGURE 35 HEARING AIDS MARKET: REVENUE ANALYSIS OF KEY PLAYERS,
2022–2024 (USD MILLION) 227
FIGURE 36 HEARING AIDS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 227
FIGURE 37 RANKING OF KEY PLAYERS IN HEARING AIDS MARKET, 2024 229
FIGURE 38 HEARING AIDS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 230
FIGURE 39 HEARING AIDS MARKET: COMPANY FOOTPRINT (KEY PLAYERS), 2024 231
FIGURE 40 HEARING AIDS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 234
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS, 2025 237
FIGURE 42 EV/EBITDA OF KEY VENDORS, 2025 238
FIGURE 43 HEARING AIDS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 238
FIGURE 44 SONOVA: COMPANY SNAPSHOT, 2024 246
FIGURE 45 WSAUDIOLOGY: COMPANY SNAPSHOT, 2024 250
FIGURE 46 DEMANT A/S: COMPANY SNAPSHOT, 2024 255
FIGURE 47 COCHLEAR LTD.: COMPANY SNAPSHOT, 2024 261
FIGURE 48 GN STORE NORD A/S: COMPANY SNAPSHOT, 2024 265
FIGURE 49 RION CO., LTD.: COMPANY SNAPSHOT, 2024 273
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11